News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Novel PARP inhibitor saruparib in metastatic hormone-sensitive prostate cancer
Photo taken from UroToday/X
Jun 24, 2024, 01:48

Novel PARP inhibitor saruparib in metastatic hormone-sensitive prostate cancer

UroToday shared a post on X:           .

“The EvoPAR-Prostate 01 Trial: Novel PARP inhibitor saruparib in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).

Neeraj Agarwal from Huntsman Cancer Institute and Zach Klaassen from Georgia Cancer Center discuss this new PARP inhibitor combined with ARPI in both biomarker-positive and negative populations.”

Proceed to the video.
Source: UroToday/X

ARPI cancer EvoPAR-Prostate 01 Trial Georgia Cancer Center Huntsman Cancer Institute Metastatic Hormone-sensitive Prostate Cancer mHSPC Neeraj Agarwal OncoDaily Oncology PARP inhibitor saruparib Zach Klaassen
Special Coverage
Blog
Feb 21, 2025, 08:19
Chibuike Okafor: How Amgen Defeated the ‘Undruggable’ KRAS
Insight
Feb 21, 2025, 06:20
Gustavo Viani: New Evidence on Elective CTV in Early Anal Cancer
Blog
Feb 21, 2025, 06:10
Afreen Shariff: Start-ups are about persistence, grit and being comfortable with being uncomfortable
Radiotherapy
Feb 21, 2025, 04:51
Radiotherapy For Breast Cancer: Types, Success Rate, Side Effects And More
Library
Feb 20, 2025, 16:36
New Paper Alert: Systemic management of advanced HCC: an increasingly complex game
Blog
Feb 20, 2025, 14:43
MD Anderson Cancer Center and Texas Children's Hospital announced a collaboration dedicated solely to pediatric cancer care
Blog
Feb 20, 2025, 11:21
Thor Halfdanarson: Should Liver resection in patients with high-grade neuroendocrine neoplasms be considered?
Blog
Feb 20, 2025, 11:19
Jill Feldman: My Guiding Compass in Advocacy
Blog
Feb 20, 2025, 11:13
Abstract submissions are open for the ESMO Gynae25
Blog
Feb 20, 2025, 11:08
Aleix Prat: In ten years we will cure 80% of cancers
Blog
Feb 20, 2025, 11:00
Akshaya Keerti: PCOS and the Hidden Risk of Endometrial Cancer
Blog
Feb 20, 2025, 10:53
Fumiko Ladd Chino: Optimizing the EHR for patient-centered communication and care